Orion Corporation: Organising meeting of the Board of Directors

Udgivet den 20-03-2024  |  kl. 15:00  |  

ORION CORPORATION
STOCK EXCHANGE RELEASE - OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE
20 MARCH 2024 at 17.00 EET

        
Orion Corporation: Organising meeting of the Board of Directors

In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Hilpi Rautelin as Vice Chairman.

The compositions of the Board committees were decided to be as follows:

Personnel and Remuneration Committee:

Veli-Matti Mattila, Chairman
Kari Jussi Aho
Maziar Mike Doustdar
Hilpi Rautelin

Audit Committee:

Ari Lehtoranta, Chairman
Eija Ronkainen
Karen Lykke Sørensen
Henrik Stenqvist  

R&D Committee:

Hilpi Rautelin, Chairman
Kari Jussi Aho
Eija Ronkainen
Karen Lykke Sørensen

The Company also has a Nomination Committee, the election of which was announced in a Stock Exchange Release on 28 April 2023.

All members of the Board of Directors have been assessed to be independent of the company and its significant shareholders.

Orion Corporation

Liisa Hurme
President and CEO		     Olli Huotari
SVP, Corporate Functions		  

                                                
Contact person:
Olli Huotari
SVP, Corporate Functions

tel. +358 50 966 3054 

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.


\Hugin

Udgivet af: NPinvestordk

Mest læste lige nu

Novo Nordisk lukker i rekordkurs
Fremadstormende rederi kan blive næste medlem af C25
Genmab gennemfører køb af Profoundbio for over 12 mia. kr.
Tirsdagens obligationer: Rentestigning forduftede efter centralbankkommentar
Europa/aktier: Medicinal klarede frisag i let sivende marked
 

Seneste nyheder

12:15 Obligationer/middag: Rolig ugestart med små renteplusser
11:40 Novo om voldsom efterspørgsel: Vi ved ikke hvornår produktionen kan følge med
11:34 Aktier/middag: Mærsk og Zealand topper ellers let sivende marked
11:26 Scandinavian Tobacco får sænket anbefaling af Deutsche Bank
11:07 Høreapparater: Sonova sendes i dørken af sænkede anbefalinger
10:21 Blackrock ser god forretning i obligationer i store økonomier med rentesænkninger forude
09:50 MT Højgaard Danmark indgår aftale med Siemens om udbygning af elnettet
09:31 Fremadstormende rederi kan blive næste medlem af C25
09:08 Aktier/åbning: Ambu i bunden af negativt marked efter sænket anbefaling
08:59 Obligationer/åbning: Renterne tikker lidt op efter amerikansk stigning mandag
08:56 Shape Robotics: Omsætningen vokser og indtjeningen falder efter opkøb
08:30 Sydbank køber Coop Bank for trecifret millionbeløb
08:07 Tyskland: Producentpriser steg en spids mindre end ventet i april - klart fald på årsbasis
08:00 Tilbagegang i BNP på 1,8 pct i første kvartal
07:56 Aktier/tendens: Ambu i fokus med sænket anbefaling før ventet lyserød start
07:20 Japanske rederier trækker fra blandt Mærsks asiatiske konkurrenter
07:13 Obligationer/tendens: Rentestigninger i sigte efter amerikanske løft i pinsen
07:08 Råvarer: Oliepriserne falder på forventninger om fortsat inflation
06:50 Ambu får sænket anbefalingen hos Svenska Handelsbanken
06:42 Asien: Japansk lyspunkt slukket i stemningsforladte markeder